Patel Gautam's Form 4 filing
Amneal Pharmaceuticals, Inc. (AMRX) · filed May 6, 2025
- Accession no.
- 0001628280-25-022719
- Filed
- May 6, 2025
- Trade date
- May 2-5, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $69.3K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Patel GautamCIK 0001738054 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 2, 2025 | Class A Common Stock | SSaleDisposed | −3,768 | $8.00 | −$30,144 | 1,725,118 | Direct | |
| May 5, 2025 | Class A Common Stock | SSaleDisposed | −4,900 | $8.00 | −$39,200 | 1,720,218 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.